Neurology Archives - Page 7 of 11

The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis

Authors: J Datt, L Baldock, E Pull, B Webber Published: Multiple sclerosis and related disorders, 2016 View publication Background Patients initiated on Gilenya (fingolimod) require cardiovascular monitoring for 6h after the first...

UK Patient Preference for Characteristics of Disease Modifying Treatments in Multiple Sclerosis

Authors: Bottomley CJ, Padania S, Lloyd AJ, Bennett G, Green C, Adlard N Published: Journal of Neurology, Neurosurgery & Psychiatry, 2016 View publication Abstract With recent Disease Modifying Treatments (DMTs) licensed in...

Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson’s disease: results from a pooled meta-analysis

Authors: D G Standaert, V Patel, S J Snedecor, S Thakkar, Y J Jalundhwala, P Kukreja, D Kratochvil, Y Bao, R Pahwa Published: Parkinsonism & Related Disorders, 2021 View publication Introduction To...

Modified delphi study of decision-making around treatment sequencing in relapsing-remitting multiple sclerosis

Authors: A M Piena, O Schoeman, J Palace, M Duddy, G T Harty, S L Wong Published: European Journal of Neurology, 2020 View publication Background Existing effectiveness models of disease-modifying drugs (DMDs)...

Symptoms of major depressive disorder scale: performance of a novel patient-reported symptom measure

Authors: D M Bushnell, K P McCarrier, E N Bush, L Abraham, C Jamieson, F McDougall, M H Trivedi, M E Thase, L Carpenter, S J Coons, PRO Consortium's Depression Working Group...

Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series

Authors: M Waddington-Cruz, H Schmidt, M F Botteman, J A Carter, M Stewart, M Hopps, S Fallet, L Amass Published: Orphanet Journal of Rare Diseases, 2019 View publication Abstract We describe 542...

Systematic review and network meta-analysis of the efficacy and safety of Lidocaine 700 mg medicated plaster vs. pregabalin

Authors: T Buksnys, N Armstrong, G Worthy, I Sabatschus, I Boesl, B Buchheister, SL Swift, C Noake, V Huertas Carrera, S Ryder, D Shah, H Liedgens, J Kleijnen Published: Current Medical Research...

Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the treatment effectiveness assessment

Authors: W Ling, V R Nadipelli, C Solem, D Farabee, N A Ronquest, B Perrochet, S M Learned, C G Deshpande, C Heidbreder Published: Substance Abuse and Rehabilitation, 2019 View publication Purpose...

Key Takeaways and Trends from the Annual Meeting of the American Academy of Neurology: Defining an Era of “New”rology

The 71st Annual Meeting of the American Academy of Neurology (AAN) was held May 4–10, 2019 in Philadelphia, PA, drawing over 15,000 participants from around the globe. I had the opportunity to attend...

News